Background Previous studies show increased morbidity in children who are HIV-exposed
but uninfected (HEU) compared to children who are HIV-unexposed uninfected (HUU). We …

Objective: To examine morbidity and mortality risk among HIV-exposed uninfected (HEU)
infants. Design: Secondary data analysis of HEU infants in a prospective cohort study of …

HIV-exposed uninfected (HEU) infants have higher infectious morbidity than HIV-unexposed
uninfected (HUU) infants. We present the clinical outcomes from a pilot cohort study of 27 …

Background: Human immunodeficiency virus (HIV) remains a major cause of pediatric
morbidity in Africa. In addition, HIV-exposed, but uninfected (HEU) infants can comprise a …

Introduction Paediatric HIV infection significantly contributes to child morbidity and mortality
in southern Africa. In Malawi as in most countries in the region, care of HIV‐exposed …

Background Almost 30% of children in Southern Africa are HIV exposed but uninfected
(HEU) and experience exposures that could increase vulnerability to infectious diseases …

Background: Much evidence of HIV-exposed uninfected (HEU) infant infectious morbidity
predates availability of maternal combination antiretroviral therapy and does not control for …

Background Fewer infants are infected with HIV through mother-to-child transmission,
making HIV-exposed but uninfected (HEU) infants a growing population. HIV-exposure …

The ZVITAMBO trial recruited 14,110 mother–infant pairs to a randomized controlled trial of
vitamin A between 1997 and 2000, before the availability of antiretroviral therapy for HIV …

Objective: To assess morbidity and mortality in HIV-exposed uninfected (HEU) children to
help guiding appropriate clinical care and effective preventive interventions. Design: This is …